Sarcoma clinical trials in New Mexico

6 actively recruiting sarcoma trials at 3 sites across New Mexico.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting NIH

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarc…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06422806

Sites in New Mexico:

University of New Mexico Cancer Center — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastase…

Sponsor: Children's Oncology Group

NCT ID: NCT05235165

Sites in New Mexico:

Presbyterian Hospital — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy usi…

Sponsor: Children's Oncology Group

NCT ID: NCT05304585

Sites in New Mexico:

University of New Mexico Cancer Center — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in New Mexico:

Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico
University of New Mexico Cancer Center — Albuquerque, New Mexico
Lovelace Women's Hospital — Albuquerque, New Mexico
Presbyterian Kaseman Hospital — Albuquerque, New Mexico
Memorial Medical Center-Las Cruces — Las Cruces, New Mexico

View on ClinicalTrials.gov →

Recruiting Network

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hyd…

Sponsor: Children's Oncology Group

NCT ID: NCT01790152

Sites in New Mexico:

University of New Mexico Cancer Center — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Recruiting Industry

BostonGene and Exigent Genomic INsight Study

The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, asse…

Sponsor: BostonGene

NCT ID: NCT06272864

Sites in New Mexico:

New Mexico Cancer Center — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20